Clinical Evaluation of Two Regimens with Different Doses of Ampicillin/Sulbactam in Patients with Ventilator Associated Pneumonia Caused By Resistant Acinetobacter Baumannii

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新: 2024年3月6日

试验速览

暂无简介。

•Patients aged more than 18 years old
•VAP diagnosis according to the IDSA guidelines (new pulmonary infiltration with clinical symptoms including fever, purulent secretions, leukocytosis, and decreased blood oxygen levels occurring after 48 hours of mechanical ventilation).
•Sign the informed consent form
•Reporting of resistance Acinetobacter in the pulmonary secretion (concurrent resistance to aminoglycosides, fluoroquinolones, cephalosporins, penicillins and carbapenems).

•Breastfeeding and pregnant patients.
•Patients who have an infection of another source other than the infection caused by the mechanical ventilation device.
•Obese patients with body mass index more than 35.
•Patients who have a history of allergy to medicines in the therapeutic regimen.
•Patients with underlying lung diseases.

发起方